Cargando…

You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations

BACKGROUND: Infections and deaths from the COVID-19 pandemic have disproportionately affected underserved populations. A community-engaged approach that supports decision making around safe COVID-19 practices is needed to promote equitable access to testing and treatment. You & Me: Test and Trea...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Agostino, Emily M., Rosenberg, Lauren M., Richmond, Alan, Damman, Allyn, Brown-Lowery, Camille, Abbot-Grimes, Princess, Siddiqui, Saira, Fadika, Tigidankay, Ward, Mark, Cooper, Mia, Sutton, Sonya, Kenton, Lindsay, Spaziano, Bob, Kasper, Janet, Barnes, Nicole, Hornik, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612258/
https://www.ncbi.nlm.nih.gov/pubmed/37898741
http://dx.doi.org/10.1186/s12889-023-16960-6
_version_ 1785128663059005440
author D’Agostino, Emily M.
Rosenberg, Lauren M.
Richmond, Alan
Damman, Allyn
Brown-Lowery, Camille
Abbot-Grimes, Princess
Siddiqui, Saira
Fadika, Tigidankay
Ward, Mark
Cooper, Mia
Sutton, Sonya
Kenton, Lindsay
Spaziano, Bob
Kasper, Janet
Barnes, Nicole
Hornik, Christoph
author_facet D’Agostino, Emily M.
Rosenberg, Lauren M.
Richmond, Alan
Damman, Allyn
Brown-Lowery, Camille
Abbot-Grimes, Princess
Siddiqui, Saira
Fadika, Tigidankay
Ward, Mark
Cooper, Mia
Sutton, Sonya
Kenton, Lindsay
Spaziano, Bob
Kasper, Janet
Barnes, Nicole
Hornik, Christoph
author_sort D’Agostino, Emily M.
collection PubMed
description BACKGROUND: Infections and deaths from the COVID-19 pandemic have disproportionately affected underserved populations. A community-engaged approach that supports decision making around safe COVID-19 practices is needed to promote equitable access to testing and treatment. You & Me: Test and Treat (YMTT) will evaluate a systematic and scalable community-engaged protocol that provides rapid access to COVID-19 at-home tests, education, guidance on next steps, and information on local resources to facilitate treatment in underserved populations. METHODS: This direct-to-participant observational study will distribute at-home, self-administered, COVID-19 testing kits to people in designated communities. YMTT features a Public Health 3.0 framework and Toolkit prescribing a tiered approach to community engagement. We will partner with two large community organizations, Merced County United Way (Merced County, CA) and Pitt County Health Department (Pitt County, NC), who will coordinate up to 20 local partners to distribute 40,000 COVID tests and support enrollment, consenting, and data collection over a 15-month period. Participants will complete baseline questions about their demographics, experience with COVID-19 infection, and satisfaction with the distribution event. Community partners will also complete engagement surveys. In addition, participants will receive guidance on COVID-19 mitigation and health-promoting resources, and accessible and affordable therapeutics if they test positive for COVID-19. Data collection will be completed using a web-based platform that enables creation and management of electronic data capture forms. Implementation measures include evaluating 1) the Toolkit as a method to form community-academic partnerships for COVID-19 test access, 2) testing results, and 3) the efficacy of a YMTT protocol coupled with local resourcing to provide information on testing, guidance, treatment, and links to resources. Findings will be used to inform innovative methods to address community needs in public health research that foster cultural relevance, improve research quality, and promote health equity. DISCUSSION: This work will promote access to COVID-19 testing and treatment for underserved populations by leveraging a community-engaged research toolkit. Future dissemination of the toolkit can support effective community-academic partnerships for health interventions in underserved settings. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05455190. Registered 13 July 2022. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-16960-6.
format Online
Article
Text
id pubmed-10612258
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106122582023-10-29 You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations D’Agostino, Emily M. Rosenberg, Lauren M. Richmond, Alan Damman, Allyn Brown-Lowery, Camille Abbot-Grimes, Princess Siddiqui, Saira Fadika, Tigidankay Ward, Mark Cooper, Mia Sutton, Sonya Kenton, Lindsay Spaziano, Bob Kasper, Janet Barnes, Nicole Hornik, Christoph BMC Public Health Study Protocol BACKGROUND: Infections and deaths from the COVID-19 pandemic have disproportionately affected underserved populations. A community-engaged approach that supports decision making around safe COVID-19 practices is needed to promote equitable access to testing and treatment. You & Me: Test and Treat (YMTT) will evaluate a systematic and scalable community-engaged protocol that provides rapid access to COVID-19 at-home tests, education, guidance on next steps, and information on local resources to facilitate treatment in underserved populations. METHODS: This direct-to-participant observational study will distribute at-home, self-administered, COVID-19 testing kits to people in designated communities. YMTT features a Public Health 3.0 framework and Toolkit prescribing a tiered approach to community engagement. We will partner with two large community organizations, Merced County United Way (Merced County, CA) and Pitt County Health Department (Pitt County, NC), who will coordinate up to 20 local partners to distribute 40,000 COVID tests and support enrollment, consenting, and data collection over a 15-month period. Participants will complete baseline questions about their demographics, experience with COVID-19 infection, and satisfaction with the distribution event. Community partners will also complete engagement surveys. In addition, participants will receive guidance on COVID-19 mitigation and health-promoting resources, and accessible and affordable therapeutics if they test positive for COVID-19. Data collection will be completed using a web-based platform that enables creation and management of electronic data capture forms. Implementation measures include evaluating 1) the Toolkit as a method to form community-academic partnerships for COVID-19 test access, 2) testing results, and 3) the efficacy of a YMTT protocol coupled with local resourcing to provide information on testing, guidance, treatment, and links to resources. Findings will be used to inform innovative methods to address community needs in public health research that foster cultural relevance, improve research quality, and promote health equity. DISCUSSION: This work will promote access to COVID-19 testing and treatment for underserved populations by leveraging a community-engaged research toolkit. Future dissemination of the toolkit can support effective community-academic partnerships for health interventions in underserved settings. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05455190. Registered 13 July 2022. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-16960-6. BioMed Central 2023-10-28 /pmc/articles/PMC10612258/ /pubmed/37898741 http://dx.doi.org/10.1186/s12889-023-16960-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
D’Agostino, Emily M.
Rosenberg, Lauren M.
Richmond, Alan
Damman, Allyn
Brown-Lowery, Camille
Abbot-Grimes, Princess
Siddiqui, Saira
Fadika, Tigidankay
Ward, Mark
Cooper, Mia
Sutton, Sonya
Kenton, Lindsay
Spaziano, Bob
Kasper, Janet
Barnes, Nicole
Hornik, Christoph
You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations
title You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations
title_full You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations
title_fullStr You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations
title_full_unstemmed You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations
title_short You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations
title_sort you & me: test and treat study protocol for promoting covid-19 test and treatment access to underserved populations
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612258/
https://www.ncbi.nlm.nih.gov/pubmed/37898741
http://dx.doi.org/10.1186/s12889-023-16960-6
work_keys_str_mv AT dagostinoemilym youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT rosenberglaurenm youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT richmondalan youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT dammanallyn youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT brownlowerycamille youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT abbotgrimesprincess youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT siddiquisaira youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT fadikatigidankay youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT wardmark youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT coopermia youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT suttonsonya youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT kentonlindsay youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT spazianobob youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT kasperjanet youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT barnesnicole youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations
AT hornikchristoph youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations